| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827543 | Schizophrenia Research | 2011 | 7 Pages |
Abstract
Cholesterol levels show a strong association with cognition in schizophrenia in all medication groups. Further research on the role of lipid metabolism in cognition may suggest new treatments for this core deficit of schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Menahem Krakowski, Pal Czobor,